| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | simoctocog alfa (Nuwiq®) |
| Formulation | 250 IU, 500 IU, 1,000 IU and 2,000 IU powder and solvent for solution for injection |
| Reference number | 2529 |
| Indication | Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Nuwiq can be used for all age groups |
| Company | Octapharma AG |
| BNF chapter | Cardiovascular system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 08/01/2015 |